<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04848025</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/19/0052</org_study_id>
    <nct_id>NCT04848025</nct_id>
  </id_info>
  <brief_title>Treatment of Central Airway Stenoses Using Computer-Assisted Customized 3d Stents TATUM</brief_title>
  <acronym>TATUM</acronym>
  <official_title>Treatment of Central Airway Stenoses Using Computer-Assisted Customized 3d Stents TATUM (Three-dimensional Airway Tailored Stent Using Computer-aided Modeling)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Airway stenting is usually efficient to treat central airway obstruction but can lead to&#xD;
      severe and potentially lethal complications (stent migration, obstructive granuloma,&#xD;
      perforation, and hemoptysis).&#xD;
&#xD;
      3D customized airway stents (computer-aided conception using CT-scan data), perfectly suited&#xD;
      to airway anatomy, should improve the tolerance and safety of airway stenting.&#xD;
&#xD;
      We demonstrated in a previous pilot study, dedicated to patients with anatomically complex&#xD;
      stenoses the safety of 3D patient-specific stents. These appealing results in highly complex&#xD;
      situations suggest the need to evaluate these devices in more common situations.&#xD;
&#xD;
      In this study we aim to test our new generation stents in all patients planned for airway&#xD;
      stenting. After computer-assisted segmentation of airways (VGStudioMAX 3.0 software), the&#xD;
      stenosis is virtually corrected, leading to the conception of a virtual stent&#xD;
      (AnatomikModeling, Toulouse), allowing for the fabrication of a mold using a 3D printer. The&#xD;
      stent is then built and sterilized (NOVATECH, Berlin) and inserted during rigid bronchoscopy.&#xD;
&#xD;
      Close follow up is then conducted, including clinical evaluation after one week, three, six&#xD;
      and 12 months; spirometry at one week, 3 months, 6 months and 12 months and chest CT-scan at&#xD;
      one week.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 17, 2021</start_date>
  <completion_date type="Anticipated">November 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of procedures with clinical improvement of the dyspnea</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of procedures with clinical improvement of the dyspnea with questionnaires of Borg, MMRC, and Dyspnea 12</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of procedures with clinical improvement of quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of procedures with clinical improvement of quality of life with the VQ11 questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of procedures with functional improvement</measure>
    <time_frame>1 seconde</time_frame>
    <description>Percentage of procedures with functional improvement ( forced expiratory volume in one second (FEV1))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of procedures with congruence of the stent</measure>
    <time_frame>1 week</time_frame>
    <description>Percentage of procedures with congruence of the stent with tracheobronchial anatomy on CT-scan at 1 week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of procedures without complications</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of procedures without complications at 1 week, 3 months, 6 months and 12 months (stent migration, obstructive granuloma, perforation, hemoptysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of procedures with clinical and functional improvement</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of procedures with clinical (dyspnea, cough, quality of life (VQ11 questionnaire)), and functional improvement (peak flow, forced expiratory volume in one second (FEV1)) at 3 months, 6 months and 12 months</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Airway Disease</condition>
  <arm_group>
    <arm_group_label>3D customized airway stents</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Custom-designed tracheobronchial prostheses</intervention_name>
    <description>Computer-assisted segmentation of airways and stent from CT data (AnatomikModeling) Fabrication of a mold and then a silicon stent by mold injection and sterilization (NOVATECH) Insertion of the stent under rigid bronchoscopy and general anesthesia</description>
    <arm_group_label>3D customized airway stents</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Complex, proximal and symptomatic (dyspnea, cough, peak flow &lt; 50%, FEV1 &lt; 50% or&#xD;
             post-stenotic infection) airway stenosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute respiratory distress, mechanical ventilation&#xD;
&#xD;
          -  Contraindication to rigid bronchoscopy (severe and irreversible coagulation disorders)&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas GUIBERT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolas GUIBERT, MCU-PH</last_name>
    <phone>5 67 77 81 60</phone>
    <phone_ext>+33</phone_ext>
    <email>guibert.n@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas GUIBERT, MCU-PH</last_name>
      <phone>5 67 77 81 60</phone>
      <phone_ext>+33</phone_ext>
      <email>guibert.n@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rigid bronchoscopy</keyword>
  <keyword>3D computer-assisted fabrication</keyword>
  <keyword>silicon-dedicated stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

